As we dive right into 2023, medical affairs teams are at a turning point.
MSLs are no longer wasting valuable time waiting in line within the halls of ivory towers, trying to get face-time or…
![The Healthcare Interoperability Policies Driving the Conversation at ViVE [Sponsored]](https://i0.wp.com/www.mediformatica.com/wp-content/uploads/2023/03/the-healthcare-interoperability-policies-driving-the-conversation-at-vive-sponsored.jpg?fit=600%2C296&ssl=1)
The Interoperability pavilion is the place to be for innovators in healthcare at this year’s ViVE conference in Nashville, March 26-29 powered by CHIME and HLTH. How healthcare organizations share patient data won’t be…
Continue Reading
Dr. Tejas Joshi, Director of Liver Diseases and Assistant Professor at Marshall University School of Medicine in Huntington, WV joins eHealth Radio and the Liver Health and Health News Channels.
Listen to interview with…
Sponsored by Consensus Cloud Solutions
March 01, 2023 – Health data exchange is essential to meaningful patient care. Providers must be able to leverage accurate and timely health information at the point of care to…
Safety is paramount in medical care, rooted in the most basic tenet of medicine: First, do no harm. But, although acute medical care presents myriad risks to patient safety, there is no category for…
Continue Reading
What You Should Know:– Bicycle Health, a telehealth provider of integrated medical and behavioral health treatment for opioid use disorder (OUD) is teaming up with Wellpath, the premier provider of localized, compassionate care to vulnerable patients…
Continue Reading
Geographic atrophy, an eye disorder that starts as a loss of central vision and progressively worsens to total blindness, now has its first treatment. The FDA on Friday approved an Apellis Pharmaceuticals drug that slows the progression of this disease, which affects more than 1 million people in the U.S.
Approval of the Apellis drug, pegcetacoplan, covers all patients with geographic atrophy, a broad label that reflects the representative patient population tested in pivotal studies, Chief Medical Officer Caroline Baumal said during a Friday evening conference call. The Waltham, Massachusetts-based company plans to launch the drug in March, marketing the product under…
Subscribe for your weekly fix of health tech stories, wherever you get your news: Apple, Spotify, or Twitter.Vijay Kedar, CEO & Co-Founder, Tomorrow HealthIn this episode, I sat down with Vijay Kedar, CEO and Co-Founder, of…
Continue Reading
By John Halamka and Paul Cerrato -Three patient populations are underrepresented in the AI models currently being developed. There are several practical solutions to the problem.
The post The Algorithmically Underserved Need Our Attention appeared first on Mayo Clinic Platform….
